Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease ; volume:19 ; number:1 ; day:17 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (17.8.2022), 1-15, 12.2022
- Urheber
-
Singh, Deepali
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-022-02565-0
- URN
-
urn:nbn:de:101:1-2022110419050656694922
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Singh, Deepali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Microglial Activation in Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation
Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer’s disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Microglial Activation in Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation
Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer’s disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
Microglial Activation in Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation